PolarCool AB

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0012570422
SEK
2.00
-3.5 (-63.64%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About PolarCool AB stock-summary
stock-summary
PolarCool AB
Pharmaceuticals & Biotechnology
Polarcool AB is a Sweden-based medical device company specializing in sports medicine. The Company focuses on of concussive and sub-concussive brain injuries. It develops a portable brain cooling device called PolarCap System. The PolarCap System consists of a cooling unit and a silicone-based cooling cap alongside neoprene insulation, cooling the head and neck via a circulating coolant during a procedure that takes approximately 45-60 minutes. The idea behind it is the reduction of brain temperature of individuals suffering from a concussion or participating in an activity where repetitive head impact occurs, such as contact and combat sports, in order to prevent or limit long term cognitive impairment. The device undergoes preclinical cohort study for concussion among hockey players and a preclinical study for indication of sub-concussive repetitive head impact among American football players.
Company Coordinates stock-summary
Company Details
Medicon Village, Scheelevagen 2 , Lund None : 223 81
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Mar 2025)
Net Profit:
-4 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

SEK 15 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.43

stock-summary
Return on Equity

-121.11%

stock-summary
Price to Book

1.36